Envision launches another reputation management campaign amid potential contract losses

Under the gun about its reputation for dumping sky-high medical bills on patients for out-of-network care, post-acute care provider Envision Healthcare has launched a second information campaign called “We Care.”

The Nashville, Tennessee-based company is aiming to better inform patients, hospitals and employers about “its commitment to negotiate a contract with UnitedHealthcare.” UnitedHealthcare, one of the nation’s largest healthcare insurance companies, signaled to Envision that it may end its contracts with the provider due to its billing practices.

Billing scrutiny

Envision has received criticism for its billing practices over the last few years. The company also owns emergency department staffing company EmCare, which has come under fire for jacking up out-of-network billing with the hospitals it contracts with. This practice typically leaves patients and insurers with significantly higher bills.

UnitedHealthcare said in September it was considering ending its contracts with Envision since the two could not come to agreements over emergency room payment agreements. UnitedHealthcare warned more than 250 hospitals may drop Envision from their networks beginning in 2019.

Envision has rebutted claims from UnitedHealthcare, though a lawsuit it launched was dismissed. The company also launched a campaign to better inform patients about surprise billing in early October.

“In truth, Envision has offered to hold its rates flat, and those rates are in line with other payors,” an announcement about Envision’s campaign reads. “Currently, more than 90 percent of Envision’s revenue is from in-network care, meaning most patients never receive a ‘surprise bill’ from Envision, as UnitedHealthcare is falsely leading patients to believe.”

A Yale study from 2017 found that EmCare contracts with hospitals had a 62 percent out-of-network billing rate.

We Care campaign

The new campaign is another attempt by Envision to improve its image and “set the record straight” about its priority of caring for patients and to negotiate contracts with UnitedHealthcare.

The current partnership between the two companies will end Dec. 31, 2018. Envision stated it has been working with UnitedHealthcare “in good faith” since January to come up with a new agreement.

“UnitedHealthcare cannot push Envision out-of-network,” an announcement about the campaign reads. “The two must work together to make sure patients continue to receive quality care and in-network coverage.”

Envision’s campaign encourages healthcare providers to “voice their concerns” if the company were to be dropped by UnitedHealthcare.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.